Awardee: Or Kakhlon
Institution: Research Fund of the Hadassah Medical Organization
Award Amount: $52,509
Testing the efficacy of new pharmaceutical candidates for APBD
Previous
Previous
What are the functional consequences of CDKL5 dysfunction in human neuronal cells?
Next
Next